Ferguson LR, Browning BL, Huebner C, Petermann I, Shelling AN, Demmers P, McCulloch A, Gearry RB, Barclay ML, Philpott M: Single nucleotide polymorphisms in human Paneth cell defensin A5 may confer susceptibility to inflammatory bowel disease in a New Zealand Caucasian population
Possible side effects are minimal but can include minor discomfort at the injection site or a cool sensation during the infusion
View the complete Cagrilintide research profile including mechanism of action, clinical studies, effectiveness timeline, and FAQ
Repeat testing is informative once the nonessential source has been stopped or enough time has passed for an injection to clear, using the same or a comparable assay so the trend is interpretable
This dual approach results in better A1c management, greater weight loss, and potentially reduced risk of diabetes complications including kidney disease and cardiovascular events